CDKN2A and squamous cell carcinoma: Interestingly, deletion of CDKN2A (p16INK4a) was strongly associated with a favourable OS in our cohort, which contrasts other reports about CDKN2A loss and a poor prognosis [38], including other squamous cell carcinomas [39, 40].